Gustavo Pereira

Dr. Gustavo Pereira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2020 in Liver International
Verified
Journal Article
Closed access
PDF file
ÁDÁlvaro Díaz-González
Álvaro Díaz-González
MZMarco Sanduzzi Zamparelli
Marco Sanduzzi Zamparelli
LFLeonardo Da Fonseca
Leonardo Da Fonseca
GCGiovan Giuseppe Di Costanzo
Giovan Giuseppe Di Costanzo
RARogerio Alves
Rogerio Alves
MRMaria Reig
Maria Reig

1 January 2020 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GPGustavo Pereira
Gustavo Pereira
CBCaroline Baldin
Caroline Baldin
JPJuliana Piedade
Juliana Piedade
VRVanessa Reis
Vanessa Reis
TVTatiana Valdeolivas
Tatiana Valdeolivas
JPJoão Luiz Pereira
João Luiz Pereira

3 January 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
CBCaroline Baldin
Caroline Baldin
JPJuliana Piedade
Juliana Piedade
LGLívia Guimarães
Lívia Guimarães
LVLívia Victor
Lívia Victor
JDJoana Duarte
Joana Duarte
GPGustavo Pereira
Gustavo Pereira

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
ABAriane Borgonovo
Ariane Borgonovo
CBCaroline Baldin
Caroline Baldin
DMDariana C. Maggi
Dariana C. Maggi
LVLivia Victor
Livia Victor
EBEmilia T. O. Bansho
Emilia T. O. Bansho
LSLeonardo L. Schiavon
Leonardo L. Schiavon
Background. Although recently challenged, systemic inflammatory response syndrome (SIRS) criteria are still commonly used in daily practice to define sepsis. However, several factors in liver cirrhosis may negatively impact its prognostic ability. Goals. To investigate the factors associated with the presence of SIRS, the characteristics of SIRS related to infection, and its prognostic value among patients hospitalized for acute decompensation of cirrhosis. Study. In this cohort study from two tertiary hospitals, 543 patients were followed up, up to 90 days. Data collection, including the prognostic models, was within 48 hours of admission. Results. SIRS was present in 42.7% of the sample and was independently associated with upper gastrointestinal bleeding (UGB), ACLF, infection, and negatively related to beta‐blockers. SIRS was associated with mortality in univariate analysis, but not in multiple Cox regression analysis. The Kaplan–Meier survival probability of patients without SIRS was 73.0% and for those with SIRS was 64.7%. The presence of SIRS was not significantly associated with mortality when considering patients with or without infection, separately. Infection in SIRS patients was independently associated with Child‐Pugh C and inversely related to UGB. Among subjects with SIRS, mortality was independently related to the presence of infection, ACLF, and Child‐Pugh C. Conclusions. SIRS was common in hospitalized patients with cirrhosis and was of no prognostic value, even in the presence of infection.

27 August 2022 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
GPGustavo Pereira
Gustavo Pereira
HPHelena R. Peixoto
Helena R. Peixoto
MGMariana L. Giusti
Mariana L. Giusti
MSMariana L. Souza
Mariana L. Souza
LVLivia B. Victor
Livia B. Victor
CVCristiane Villela-Nogueira
Cristiane Villela-Nogueira
The outcomes regarding portal hypertension-related complications and infections after HCV cure in decompensated cirrhosis are scarcely reported. We aimed to identify the predictors of survival and to evaluate the frequency of decompensation events of cirrhosis, including hepatocellular carcinoma (HCC), portal hypertension complications and infections in a cohort of decompensated cirrhotic with sustained virological response (SVR) in a real-world scenario. This was a prospective study in consecutive HCV-infected patients with decompensated cirrhosis who achieved SVR after direct-acting antiviral (DAA) treatment. At baseline, clinical and laboratory data were recorded. Patients were followed until development of outcomes regarding further decompensation, death, or liver transplant. A Cox-regression analysis was performed and survival curves were constructed using the Kaplan Mayer method. One hundred and thirty patients (age 60 ± 9 years, 64% female, 70% genotype 1) were included and followed-up through three years. SVR was associated with a lower prevalence of ascites and an improvement in Child-Pugh and MELD scores. One and three-year probability of transplant-free survival was 93% and 66%, respectively. Variables related to three-years survival were MELD < 11 (HR 1.24, 95% CI 1.13-1.37) and absence of ascites (HR 2.03, 95% CI 0.99-4.13) after the end of treatment (91% versus 37% in patients with ascites and a higher MELD, p < 0.001). Decompensated cirrhotics with SVR and a low MELD without ascites have an excellent long-term prognosis. On the contrary, those with higher MELD and ascites have a low probability of survival even in the short term and might be evaluated for liver transplantation.

Verified
Journal Article
Open access
PDF file
ZVZulane S. T. Veiga
Zulane S. T. Veiga
FFFlávia F. Fernandes
Flávia F. Fernandes
LGLívia Guimarães
Lívia Guimarães
JPJuliana Piedade
Juliana Piedade
GPGustavo Pereira
Gustavo Pereira
Background: Hepatosplenic schistosomiasis (HSS) is a peculiar form of non-cirrhotic portal hypertension (NCPH). Although HSS patients present normal hepatic function, some evolve signs of hepatocellular failure and features of decompensated cirrhosis. The natural history of HSS-NCPH is unknown. Methods: A retrospective study was conducted that evaluated patients who fulfilled clinical-laboratorial criteria for HSS. Results: A total of 105 patients were included. Eleven patients already presented with decompensated disease and had lower transplant-free survival at 5 years than those without (61% vs. 95%, p = 0.015). Among 94 patients without prior decompensation, the median follow-up was 62 months and 44% of them had varicose bleeding (two or more episodes in 27%). Twenty-one patients presented at least one episode of decompensation (10-year probability 38%). Upon multivariate analysis, varicose bleeding and higher bilirubin levels were associated with decompensation. The 10-year probability of survival was 87%. Development of decompensation and age were predictive of mortality. Conclusion: HSS is characterized by multiple episodes of GI bleeding, a high probability of decompensation and reduced survival at the end of the first decade. Decompensation is more common in patients with varicose esophageal bleeding and is associated with lower survival.